Acura Pharmaceuticals, Inc. is a publicly traded company listed under the stock symbol ACUR on the NASDAQ Capital Market®. Our Securities and Exchange Commission (SEC) Central Index Key (CIK) is: 0000786947.

We encourage all current and potential new investors to review our Risk Factors, SEC Filings and Press Releases. Investor inquiries may be made to Peter A. Clemens, the Company's Senior Vice President of Investor Relations and Chief Financial Officer. 

You may click on  ACUR to access the Company's stock price from Yahoo® and click on the links below to access our recent SEC Filings.